Suki
Suki develops AI software that helps clinicians document visits and healthcare technology vendors embed clinical assistance in their products.
$90MSeries E
ParticipantV
Venrock
Activity from announced rounds
All recorded activity
Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.
Recorded funding activity
Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.
- Rounds participated in
- 5
- Confirmed lead rounds
- 0 3 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $509M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in all activityEncoded Therapeutics Inc.
Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.
$275MSeries F
ParticipantGitar
Builds AI agents for code review and continuous integration workflows
$9MUndisclosed
Role not disclosedAdcendo
Adcendo develops antibody-drug conjugates that deliver cancer drugs to tumor-associated targets, with clinical programs in solid tumors and soft tissue sarcoma.
$75MSeries C
Role not disclosedGenLogs
Provides a truck intelligence platform using roadside sensors and AI to secure freight networks
$60MSeries B
Role not disclosed